During the past decade, Lee Memorial Health System conducted 6 clinical trials. In the 10-year time frame, 6 clinical trials started and 51 clinical trials were completed, i.e. on average, 850% percent of trials that started reached the finish line to date. In the past 5 years, 3 clinical trials started and 19 clinical trials were completed. i.e. 633.3% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Lee Memorial Health System" #1 sponsor was "Children's Oncology Group" with 49 trials, followed by "National Cancer Institute (NCI)" with 20 trials sponsored, "AltaRex" with 1 trials sponsored, "Arthrex, Inc." with 1 trials sponsored and "AtriCure, Inc." with 1 trials sponsored. Other sponsors include 4 different institutions and companies that sponsored additional 14 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Lee Memorial Health System" #1 collaborator was "National Cancer Institute (NCI)" with 52 trials as a collaborator, "NRG Oncology" with 2 trials as a collaborator, "Cancer and Leukemia Group B" with 1 trials as a collaborator, "Children's Oncology Group" with 1 trials as a collaborator and "EsPhALL" with 1 trials as a collaborator. Other collaborators include -1 different institutions and companies that were collaborators in the rest 9 trials.

According to Clinical.Site data, the most researched conditions in "Lee Memorial Health System" are "Acute Lymphoblastic Leukemia" (8 trials), "Previously Treated Childhood Rhabdomyosarcoma" (6 trials), "Recurrent Childhood Rhabdomyosarcoma" (6 trials), "Recurrent Neuroblastoma" (6 trials) and "Rhabdomyosarcoma" (5 trials). Many other conditions were trialed in "Lee Memorial Health System" in a lesser frequency.

Most popular intervention types in "Lee Memorial Health System" are "Other" (59 trials), "Drug" (57 trials), "Biological" (30 trials), "Radiation" (20 trials) and "Procedure" (17 trials). Other intervention types were less common.

The name of intervention was led by "Laboratory Biomarker Analysis" (36 trials), "Cyclophosphamide" (17 trials), "Vincristine Sulfate" (15 trials), "Doxorubicin Hydrochloride" (14 trials) and "Etoposide" (13 trials). Other intervention names were less common.

The vast majority of trials in "Lee Memorial Health System" are 77 trials for "All" genders and 4 trials for "Female" genders.

Currently, there are NaN active trials in "Lee Memorial Health System". undefined are not yet recruiting, 7 are recruiting, 28 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 44 completed trials in Lee Memorial Health System, undefined suspended trials, and undefined terminated clinical trials to date.

Out of the total trials that were conducted in Lee Memorial Health System, 1 "Phase 1" clinical trials were conducted, 22 "Phase 2" clinical trials and 38 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 4 trials that are defined as “Not Applicable".

Lee Memorial Health System has several departments that took part in Clinical trials: "Golisano Children's Hospital of Southwest Florida" - 153 trials, "Lee Cancer Care of Lee Memorial Health System" - 36 trials, "Regional Cancer Center-Lee Memorial Health System" - 28 trials